Abstract
Ovarian hyperstimulation syndrome (OHSS) is an exaggerated response to ovulation induction (OI) therapy. Severe OHSS is estimated to occur in around 1% of all gonadotropin cycles. It is characterized by cystic enlargement of the ovaries and transudation of fluid and proteins from the intravascular compartment into the third space due to increased capillary permeability, considered as a potentially fatal complication of ovarian stimulation. This article aims to revise recent data and trends in the diagnosis and treatment of this potentially serious complication of a rapidly expanding therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
